These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39501325)

  • 1. Emerging threat of artemisinin partial resistance markers (pfk13 mutations) in Plasmodium falciparum parasite populations in multiple geographical locations in high transmission regions of Uganda.
    Agaba BB; Travis J; Smith D; Rugera SP; Zalwango MG; Opigo J; Katureebe C; Mpirirwe R; Bakary D; Antonio M; Khalid B; Ngonzi J; Kamya MR; Kaleebu P; Piot P; Cheng Q
    Malar J; 2024 Nov; 23(1):330. PubMed ID: 39501325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective analysis of
    Ogwang R; Osoti V; Wamae K; Ndwiga L; Muteru K; Ningwa A; Tuju J; Kinyanjui S; Osier F; Marsh K; Bejon P; Idro R; Ochola-Oyier LI
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0157623. PubMed ID: 39136465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spread of molecular markers of artemisinin partial resistance and diagnostic evasion in Eritrea: a retrospective molecular epidemiology study.
    Mihreteab S; Anderson K; Fuente IM; Sutherland CJ; Smith D; Cunningham J; Beshir KB; Cheng Q
    Lancet Microbe; 2024 Dec; ():100930. PubMed ID: 39653047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited threat of Plasmodium falciparum pfhrp2 and pfhrp3 gene deletion to the utility of HRP2-based malaria RDTs in Northern Uganda.
    Agaba BB; Smith D; Travis J; Pasay C; Nabatanzi M; Arinaitwe E; Ssewanyana I; Nabadda S; Cunningham J; Kamya MR; Cheng Q
    Malar J; 2024 Jan; 23(1):3. PubMed ID: 38167003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Plasmodium falciparum malaria 1991-2019.
    Rathmes G; Rumisha SF; Lucas TCD; Twohig KA; Python A; Nguyen M; Nandi AK; Keddie SH; Collins EL; Rozier JA; Gibson HS; Chestnutt EG; Battle KE; Humphreys GS; Amratia P; Arambepola R; Bertozzi-Villa A; Hancock P; Millar JJ; Symons TL; Bhatt S; Cameron E; Guerin PJ; Gething PW; Weiss DJ
    Malar J; 2020 Oct; 19(1):374. PubMed ID: 33081784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H.
    Pacheco MA; Schneider KA; Cheng Q; Munde EO; Ndege C; Onyango C; Raballah E; Anyona SB; Ouma C; Perkins DJ; Escalante AA
    Malar J; 2020 Oct; 19(1):378. PubMed ID: 33092587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal evolution of sulfadoxine-pyrimethamine resistance genotypes and genetic diversity in response to a decade of increased interventions against Plasmodium falciparum in northern Ghana.
    Amenga-Etego LN; Asoala V; Agongo G; Jacob C; Goncalves S; Awandare GA; Rockett KA; Kwiatkowski D
    Malar J; 2021 Mar; 20(1):152. PubMed ID: 33731134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal and spatial dynamics of Plasmodium falciparum clonal lineages in Guyana.
    Vanhove M; Schwabl P; Clementson C; Early AM; Laws M; Anthony F; Florimond C; Mathieu L; James K; Knox C; Singh N; Buckee CO; Musset L; Cox H; Niles-Robin R; Neafsey DE
    PLoS Pathog; 2024 Jun; 20(6):e1012013. PubMed ID: 38870266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyronaridine-artesunate or dihydroartemisinin-piperaquine combined with single low-dose primaquine to prevent
    Stone W; Mahamar A; Sanogo K; Sinaba Y; Niambele SM; Sacko A; Keita S; Youssouf A; Diallo M; Soumare HM; Kaur H; Lanke K; Ter Heine R; Bradley J; Issiaka D; Diawara H; Traore SF; Bousema T; Drakeley C; Dicko A
    Lancet Microbe; 2022 Jan; 3(1):e41-e51. PubMed ID: 35028628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geo-classification of drug-resistant travel-associated
    Pierre-Louis E; Kelley J; Patel D; Carlson C; Talundzic E; Jacobson D; Barratt JLN
    Antimicrob Agents Chemother; 2024 Dec; 68(12):e0120324. PubMed ID: 39530682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a parasite-density based pooled targeted amplicon deep sequencing (TADS) method for molecular surveillance of Plasmodium falciparum drug resistance genes in Haiti.
    Louha S; Herman C; Gupta M; Patel D; Kelley J; Oh JM; Guru J; Lemoine JF; Chang MA; Venkatachalam U; Rogier E; Talundzic E
    PLoS One; 2022; 17(1):e0262616. PubMed ID: 35030215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive analysis of drug resistance molecular markers and Plasmodium falciparum genetic diversity in two malaria endemic sites in Mali.
    Diakité SAS; Traoré K; Sanogo I; Clark TG; Campino S; Sangaré M; Dabitao D; Dara A; Konaté DS; Doucouré F; Cissé A; Keita B; Doumbouya M; Guindo MA; Toure MB; Sogoba N; Doumbia S; Awandare GA; Diakité M
    Malar J; 2019 Nov; 18(1):361. PubMed ID: 31718631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance.
    Ishengoma DS; Mandara CI; Bakari C; Fola AA; Madebe RA; Seth MD; Francis F; Buguzi CC; Moshi R; Garimo I; Lazaro S; Lusasi A; Aaron S; Chacky F; Mohamed A; Njau RJA; Kitau J; Rasmussen C; Bailey JA; Juliano JJ; Warsame M
    Lancet Infect Dis; 2024 Nov; 24(11):1225-1233. PubMed ID: 39159633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two decades of molecular surveillance in Senegal reveal rapid changes in known drug resistance mutations over time.
    Ndiaye YD; Wong W; Thwing J; Schaffner SF; Brenneman KV; Tine A; Diallo MA; Deme AB; Sy M; Bei AK; Thiaw AB; Daniels R; Ndiaye T; Gaye A; Ndiaye IM; Toure M; Gadiaga N; Sene A; Sow D; Garba MN; Yade MS; Dieye B; Diongue K; Zoumarou D; Ndiaye A; Gomis JF; Fall FB; Ndiop M; Diallo I; Sene D; Macinnis B; Seck MC; Ndiaye M; Ngom B; Diedhiou Y; Mbaye AM; Ndiaye L; Sy N; Badiane AS; Hartl DL; Wirth DF; Volkman SK; Ndiaye D
    Malar J; 2024 Jul; 23(1):205. PubMed ID: 38982475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinin-resistant malaria.
    White NJ; Chotivanich K
    Clin Microbiol Rev; 2024 Dec; 37(4):e0010924. PubMed ID: 39404268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum population dynamics in East Africa and genomic surveillance along the Kenya-Uganda border.
    Osborne A; Mańko E; Waweru H; Kaneko A; Kita K; Campino S; Gitaka J; Clark TG
    Sci Rep; 2024 Aug; 14(1):18051. PubMed ID: 39103358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of selection and timelines for the continued spread of artemisinin and partner drug resistance in Africa.
    Watson OJ; Muchiri S; Ward A; Meier-Sherling C; Asua V; Katairo T; Brewer T; Cuomo-Dannenburg G; Winskill P; Bailey JA; Okell L; Scudu G; Woolsey AM
    medRxiv; 2024 Aug; ():. PubMed ID: 39252921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data meta-analysis.
    Roh ME; Gutman J; Murphy M; Hill J; Madanitsa M; Kakuru A; Barsosio HC; Kariuki S; Lusingu JPA; Mosha F; Kajubi R; Kamya MR; Mathanga D; Chinkhumba J; Laufer MK; Mlugu E; Kamuhabwa AAR; Aklillu E; Minzi O; Okoro RN; Geidam AD; Ohieku JD; Desai M; Jagannathan P; Dorsey G; Ter Kuile FO
    medRxiv; 2024 Nov; ():. PubMed ID: 39649586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the daily natural history of asymptomatic Plasmodium infections in adults and older children in Katakwi, Uganda: a longitudinal cohort study.
    Hergott DEB; Owalla TJ; Staubus WJ; Seilie AM; Chavtur C; Balkus JE; Apio B; Lema J; Cemeri B; Akileng A; Chang M; Egwang TG; Murphy SC
    Lancet Microbe; 2024 Jan; 5(1):e72-e80. PubMed ID: 38185134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.